Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Bioorganic & Medicinal Chemistry Letters
|
August 20, 2022
Discovery of a selective c-MET inhibitor with a novel binding mode
Gavin W Collie, Louise Barlind, Sana Bazzaz, et al.
Cells
|
March 13, 2024
The Combination of Vascular Endothelial Growth Factor A (VEGF-A) and Fibroblast Growth Factor 1 (FGF1) Modified mRNA Improves Wound Healing in Diabetic Mice: An Ex Vivo and In Vivo Investigation
Sandra Tejedor, Maria Wågberg, Cláudia Correia, et al.
ACS Medicinal Chemistry Letters
|
September 19, 2019
Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET Inhibitors
Gavin W Collie, Cheryl M Koh, Daniel J O'Neill, et al.
Chemmedchem
|
July 21, 2019
An Angle on MK2 Inhibition-Optimization and Evaluation of Prevention of Activation Inhibitors
Ulf Hedström, Monica Norberg, Emma Evertsson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 28, 2025
Preclinical evaluation and first-in-human phase 1 trial of AZD0186, a novel, oral small molecule glucagon-like peptide-1 receptor agonist
Weier Qi, Simina M Boca, Alessandro Boianelli, et al.
Pain
|
May 3, 2019
Antibodies binding the head domain of P2X4 inhibit channel function and reverse neuropathic pain
Wendy A Williams, John E Linley, Clare A Jones, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
January 10, 2018
Agonists and Antagonists of Protease-Activated Receptor 2 Discovered within a DNA-Encoded Chemical Library Using Mutational Stabilization of the Target
Dean G Brown, Giles A Brown, Paolo Centrella, et al.
Nature
|
April 27, 2017
Structural insight into allosteric modulation of protease-activated receptor 2
Robert K Y Cheng, Cédric Fiez-Vandal, Oliver Schlenker, et al.
Journal of Medicinal Chemistry
|
June 21, 2023
Discovery and Optimization of the First ATP Competitive Type-III c-MET Inhibitor
Iacovos N Michaelides, Gavin W Collie, Ulf Börjesson, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Bioorganic & Medicinal Chemistry Letters
|
August 20, 2022
Discovery of a selective c-MET inhibitor with a novel binding mode
Gavin W Collie, Louise Barlind, Sana Bazzaz, et al.
Cells
|
March 13, 2024
The Combination of Vascular Endothelial Growth Factor A (VEGF-A) and Fibroblast Growth Factor 1 (FGF1) Modified mRNA Improves Wound Healing in Diabetic Mice: An Ex Vivo and In Vivo Investigation
Sandra Tejedor, Maria Wågberg, Cláudia Correia, et al.
ACS Medicinal Chemistry Letters
|
September 19, 2019
Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET Inhibitors
Gavin W Collie, Cheryl M Koh, Daniel J O'Neill, et al.
Chemmedchem
|
July 21, 2019
An Angle on MK2 Inhibition-Optimization and Evaluation of Prevention of Activation Inhibitors
Ulf Hedström, Monica Norberg, Emma Evertsson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 28, 2025
Preclinical evaluation and first-in-human phase 1 trial of AZD0186, a novel, oral small molecule glucagon-like peptide-1 receptor agonist
Weier Qi, Simina M Boca, Alessandro Boianelli, et al.
Pain
|
May 3, 2019
Antibodies binding the head domain of P2X4 inhibit channel function and reverse neuropathic pain
Wendy A Williams, John E Linley, Clare A Jones, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
January 10, 2018
Agonists and Antagonists of Protease-Activated Receptor 2 Discovered within a DNA-Encoded Chemical Library Using Mutational Stabilization of the Target
Dean G Brown, Giles A Brown, Paolo Centrella, et al.
Nature
|
April 27, 2017
Structural insight into allosteric modulation of protease-activated receptor 2
Robert K Y Cheng, Cédric Fiez-Vandal, Oliver Schlenker, et al.
Journal of Medicinal Chemistry
|
June 21, 2023
Discovery and Optimization of the First ATP Competitive Type-III c-MET Inhibitor
Iacovos N Michaelides, Gavin W Collie, Ulf Börjesson, et al.
Page
of 3